Dr Viranchi Shah on India Pharma Inc’s balancing act between aspirations, expectations and realities Read more
Advancing Nitrosamine Control: A Strategic Path to Regulatory Confidence and Safer Medicines Read more
Anil Matai, Director General of OPPI, on the Future of Indian Pharma: From Product Provider to Health Partner Read more
Panel Discussion: Building a high-value pharma destination: Making Chandigarh–Baddi investor-ready Read more